glp 1 ra examples Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review GLP-1RA Essentials in Gastroenterology: Side

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or pharmacies could compound drugs that were essentially copies of either semaglutide (available under the brand names Ozempic, Rybelsus, and Wegovy) and tirzepatide (available under the brand names Mounjaro, and Zepbound).

Track GLP-1 shots, reminders, injection sites, dose history, side effects, food, water, and progress in one app for Wegovy, Zepbound, Mounjaro, and more.

While not statistically significant, GLP-1 RAs also exhibited a trend towards fewer myocardial infarctions (HR 0.83) and lower mortality rates (HR 0.83) than SGLT2 inhibitors

President Trump signs an executive order that aims to cut prescription drug costs in the U.S

Show your support for accessible healthcare and medical innovation.